A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Cáncer de los testículos; Tumor de células germinativas; Cáncer testicular no seminoma; Cáncer testicular seminoma
La Fuerza de Tarea de Servicios Preventivos de los Estados Unidos (U.S. Preventive Services Task Force) desaconseja las pruebas de detección rutinarias para cáncer testicular, debido a que no hay una técnica de detección efectiva conocida. Esta recomendación no se aplica si hay un antecedente personal de criptorquidia.
Einhorn LH. Testicular cancer. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 210.
Screening for testicular cancer. U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality. 2011. Accessed April 2011.
National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Testicular cancer. v.2.2011.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885